Who
Nicolas Barthelemy
Director
Company insider
Files Form 4 as: Director, Repligen; Director, Twist Bioscience; VP, Corporate Development, 908 Devices; Director, Standard BioTools; Pres, Commercial Operations, Life Technologies.
In numbers
- Trades disclosed
- 266
- Buys
- 6
- Sells
- 38
- Bought
- $1.1M
- Sold
- $16.8M
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 13 Mar 2006
- Last trade
- 14 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 18 May 2026 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —995 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,239 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,239 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —995 at $0.00 | filing |
| 15 May 2025filed 21 May 2025 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,800 at $0.00 | filing |
| 15 May 2025filed 21 May 2025 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —973 at $0.00 | filing |
| 14 Jun 2024filed 14 Jun 2024 | RGEN RepligenBiotechnology | SEC FORM 4 Bought | $151K1,200 at $125.45 | filing |
| 16 May 2024filed 20 May 2024 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,376 at $0.00 | filing |
| 16 May 2024filed 20 May 2024 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —701 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,487 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —686 at $0.00 | filing |
| 21 Nov 2022filed 23 Nov 2022 | TWST Twist Bioscienceoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code M | —9,082 at $0.00 | filing |
| 21 Nov 2022filed 23 Nov 2022 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code M | $212K9,082 at $23.33 | filing |
| 15 Jun 2022filed 17 Jun 2022 | MASS 908 Devicesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,379 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | MASS 908 DevicesLife-science tools | SEC FORM 4 Code M | —1,379 | filing |
| 26 May 2022filed 31 May 2022 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,298 at $0.00 | filing |
| 26 May 2022filed 31 May 2022 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —534 at $0.00 | filing |
| 11 May 2022filed 13 May 2022 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Bought | $250K8,550 at $29.25 | filing |
| 1 Apr 2022filed 4 Apr 2022 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code M | $79K20,993 at $3.74 | filing |
| 1 Apr 2022filed 4 Apr 2022 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code M | $79K20,993 at $3.74 | filing |
News
Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisTWST · tickerreport.com · 15 Oct 2026908 Devices (NASDAQ:MASS) Director Christopher Brown Sells 30,000 Shares of Company StockMASS · dailypolitical.com · 10 Oct 2026Insider Selling: 908 Devices (NASDAQ:MASS) CFO Sells $65,150.00 in StockMASS · tickerreport.com · 8 Oct 2026908 Devices (NASDAQ:MASS) Stock: Insider Joseph Iv Griffith Sells 5,000 SharesMASS · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Nicolas Barthelemy; 4 articles from the last 14 days about the 4 companies they traded most, at most three about any one of them.